1. Home
  2. IBEX vs SLDB Comparison

IBEX vs SLDB Comparison

Compare IBEX & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IBEX Limited

IBEX

IBEX Limited

N/A

Current Price

$49.40

Market Cap

576.0M

Sector

Technology

ML Signal

N/A

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

N/A

Current Price

$6.64

Market Cap

623.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IBEX
SLDB
Founded
2017
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
576.0M
623.0M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
IBEX
SLDB
Price
$49.40
$6.64
Analyst Decision
Hold
Strong Buy
Analyst Count
2
14
Target Price
★ $42.00
$18.71
AVG Volume (30 Days)
75.1K
★ 1.3M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
32.63
★ 34.97
EPS
★ 0.99
N/A
Revenue
★ $644,076,000.00
$8,094,000.00
Revenue This Year
$10.59
N/A
Revenue Next Year
$6.75
N/A
P/E Ratio
$14.28
★ N/A
Revenue Growth
★ 15.37
N/A
52 Week Low
$25.94
$4.01
52 Week High
$48.17
$11.45

Technical Indicators

Market Signals
Indicator
IBEX
SLDB
Relative Strength Index (RSI) 67.35 50.48
Support Level $29.07 $6.25
Resistance Level N/A $7.42
Average True Range (ATR) 1.79 0.45
MACD -0.19 0.13
Stochastic Oscillator 100.00 88.38

Price Performance

Historical Comparison
IBEX
SLDB

About IBEX IBEX Limited

IBEX Ltd delivers business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. The company's services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital), and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare, among others, and derives maximum revenue from the United States.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: